Aberrations in PI3K/AKT/mTORC1 signaling have been identified in approximately 40% of early PCa cases and 70–100% in advanced cases and metastasic tumors (Taylor et al., 2010; Carver et al., 2011). The gene discussed is PIK3CA; the disease is posterior cortical atrophy.